We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

73 hedge funds and large institutions have $238M invested in Minerva Neurosciences in 2018 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 36 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

671% more call options, than puts

Call options by funds: $131K | Put options by funds: $17K

200% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 12

100% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 6

35% more capital invested

Capital invested by funds: $177M → $238M (+$61.4M)

9% more funds holding

Funds holding: 67 → 73 (+6)

0.19% more ownership

Funds ownership: 9.11% → 9.3% (+0.19%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
73
Holders Change
+6
Holders Change %
+8.96%
% of All Funds
1.67%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
36
Reduced
12
Closed
6
Calls
$131K
Puts
$17K
Net Calls
+$114K
Net Calls Change
+$114K

Top Buyers

Rank Fund Capital Flow
1
JG
Jefferies Group
New York
+$2.43M
2
NC
Northpointe Capital
Michigan
+$1.94M
3
BlackRock
BlackRock
New York
+$1.67M
4
MCM
Moore Capital Management
New York
+$1.52M
5
Renaissance Technologies
Renaissance Technologies
New York
+$944K

Top Sellers

Rank Fund Capital Flow
1
HCMT
Highland Capital Management (Texas)
Texas
-$4.08M
2
AG
Artal Group
Luxembourg
-$1.88M
3
JP Morgan Chase
JP Morgan Chase
New York
-$1.56M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$1.07M
5
MWNA
Marshall Wace North America
New York
-$606K
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$62.2M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$37.7M – – –
BlackRock
3
BlackRock
New York
$18M +$1.67M +27,426 +11%
HCMT
4
Highland Capital Management (Texas)
Texas
$14.1M -$4.08M -67,136 -24%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$12.6M -$1.07M -17,621 -8%
Vanguard Group
6
Vanguard Group
Pennsylvania
$12.5M +$879K +14,469 +8%
Franklin Resources
7
Franklin Resources
California
$10.7M +$500K +8,227 +5%
Millennium Management
8
Millennium Management
New York
$7.59M +$191K +3,137 +3%
IVAV
9
Index Venture Associates V
Jersey
$7.52M – – –
SFM
10
Sphera Funds Management
Israel
$6.77M +$343K +5,640 +6%
CAM
11
Cormorant Asset Management
Massachusetts
$5.01M – – –
State Street
12
State Street
Massachusetts
$3.94M +$75.1K +1,237 +2%
MWNA
13
Marshall Wace North America
New York
$3.44M -$606K -9,984 -16%
JP Morgan Chase
14
JP Morgan Chase
New York
$3.25M -$1.56M -25,692 -34%
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$3.23M +$854K +14,057 +40%
Northern Trust
16
Northern Trust
Illinois
$2.96M +$430K +7,074 +19%
JG
17
Jefferies Group
New York
$2.64M +$2.43M +40,021 New
Geode Capital Management
18
Geode Capital Management
Massachusetts
$2.45M +$191K +3,147 +9%
NC
19
Northpointe Capital
Michigan
$2.11M +$1.94M +31,974 New
MCM
20
Moore Capital Management
New York
$1.65M +$1.52M +25,000 New
Renaissance Technologies
21
Renaissance Technologies
New York
$1.45M +$944K +15,550 +241%
TCIM
22
TIAA CREF Investment Management
New York
$1.4M +$118K +1,942 +10%
BCM
23
Bridgeway Capital Management
Texas
$1.2M – – –
DCM
24
DAFNA Capital Management
California
$1.08M -$305K -5,028 -24%
Handelsbanken Fonder
25
Handelsbanken Fonder
Sweden
$1.03M +$228K +3,750 +32%
1
2 3 4

NERV Hedge Fund Activity: Q2 2018 in Review

73 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q2 2018, worth a combined $238M — up 35% from $177M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new NERV positions and 6 closed out — a net gain of 6 holders — while 36 added to existing stakes and 12 trimmed.

The largest buyer was Jefferies Group, opening a new position worth an estimated $2.43M. The largest seller was Highland Capital Management (Texas), cutting an estimated $4.08M.

  • 73 institutional investors held Minerva Neurosciences (NERV) as of Q2 2018, up from 67 in Q1 2018.
  • Funds reported $238M of Minerva Neurosciences stock for Q2 2018, up 35% quarter-over-quarter.
  • 12 funds opened new Minerva Neurosciences positions in Q2 2018 and 6 closed out, a net change of +6 holders.
  • The largest Minerva Neurosciences buyer in Q2 2018 was Jefferies Group, an estimated $2.43M added.
  • The largest Minerva Neurosciences seller in Q2 2018 was Highland Capital Management (Texas), an estimated $4.08M sold.

Based on aggregated 13F filings for Q2 2018.